Antonio Rosato

14.0k total citations · 5 hit papers
229 papers, 10.4k citations indexed

About

Antonio Rosato is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Antonio Rosato has authored 229 papers receiving a total of 10.4k indexed citations (citations by other indexed papers that have themselves been cited), including 92 papers in Oncology, 87 papers in Molecular Biology and 76 papers in Immunology. Recurrent topics in Antonio Rosato's work include Immunotherapy and Immune Responses (41 papers), Immune Cell Function and Interaction (36 papers) and CAR-T cell therapy research (27 papers). Antonio Rosato is often cited by papers focused on Immunotherapy and Immune Responses (41 papers), Immune Cell Function and Interaction (36 papers) and CAR-T cell therapy research (27 papers). Antonio Rosato collaborates with scholars based in Italy, United States and Germany. Antonio Rosato's co-authors include Stefano Piccolo, Michelangelo Cordenonsi, Silvio Bicciato, Sirio Dupont, Mattia Forcato, Luca Azzolin, Paola Zanovello, Francesca Zanconato, A. Parenti and Roberta Sommaggio and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Antonio Rosato

221 papers receiving 10.3k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Hippo Transducer TAZ Confers Cancer Stem Cell-Related Traits on Breast Cancer Cells

2011 1.0k citations Antonio Rosato, Marco Montagner et al. profile →
Genome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth

2015 840 citations Antonio Rosato et al. profile →
A Mutant-p53/Smad Complex Opposes p63 to Empower TGFβ-Induced Metastasis

2009 650 citations Marco Montagner, Sara Bobisse et al. profile →
Metabolic control of YAP and TAZ by the mevalonate pathway

2014 620 citations Antonio Rosato et al. profile →
A MicroRNA Targeting Dicer for Metastasis Control

2010 541 citations Graziano Martello, Antonio Rosato et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Antonio Rosato Italy	45	5.6k	3.3k	2.7k	1.8k	1.7k	229	10.4k
Valerie G. Brunton United Kingdom	52	6.8k 1.2×	4.0k 1.2×	3.0k 1.1×	1.1k 0.6×	2.4k 1.4×	149	12.1k
Jonathan P. Sleeman Germany	54	7.3k 1.3×	4.7k 1.4×	3.1k 1.1×	2.1k 1.2×	2.3k 1.3×	167	13.1k
Michael F. Olson United Kingdom	46	6.9k 1.2×	2.4k 0.7×	3.5k 1.3×	1.4k 0.8×	1.1k 0.6×	132	10.7k
Clare M. Isacke United Kingdom	57	4.9k 0.9×	2.5k 0.8×	2.0k 0.7×	1.2k 0.7×	1.8k 1.0×	141	8.5k
Karl R. Clauser United States	49	7.2k 1.3×	2.2k 0.7×	1.5k 0.5×	1.5k 0.8×	1.1k 0.6×	84	11.6k
Andréas Bikfalvi France	52	5.0k 0.9×	1.8k 0.6×	1.5k 0.5×	998 0.5×	1.6k 0.9×	182	8.3k
Motowo Nakajima Japan	54	5.9k 1.1×	2.7k 0.8×	3.1k 1.1×	793 0.4×	2.2k 1.3×	225	10.3k
Kevin P. Claffey United States	52	7.6k 1.4×	3.0k 0.9×	1.2k 0.4×	1.4k 0.8×	2.5k 1.5×	98	11.7k
Martin Götte Germany	53	6.1k 1.1×	1.6k 0.5×	4.8k 1.7×	1.9k 1.0×	2.0k 1.2×	214	11.2k
Nobuyuki Takakura Japan	54	5.5k 1.0×	2.8k 0.8×	1.3k 0.5×	2.6k 1.4×	1.4k 0.8×	182	11.1k

Countries citing papers authored by Antonio Rosato

Since Specialization

Citations

This map shows the geographic impact of Antonio Rosato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Rosato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Rosato more than expected).

Fields of papers citing papers by Antonio Rosato

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio Rosato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Rosato. The network helps show where Antonio Rosato may publish in the future.

Co-authorship network of co-authors of Antonio Rosato

This figure shows the co-authorship network connecting the top 25 collaborators of Antonio Rosato. A scholar is included among the top collaborators of Antonio Rosato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio Rosato. Antonio Rosato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zordan, Paola, Matteo Grioni, Anna Tosi, et al.. (2025). Microbiome modulation uncouples efficacy and toxicity induced by immune checkpoint blockade in mouse multiple myeloma. Nature Communications. 16(1). 10384–10384.

Attanasio, Andrea, Lara Tondi, Antonia Camporeale, et al.. (2025). Dobutamine stress cardiac magnetic resonance role in patients with anomalous aortic origin of coronary arteries. European Heart Journal - Cardiovascular Imaging. 26(7). 1292–1302.

Pocaterra, Arianna, Antonio Citro, Chiara Gnasso, et al.. (2024). A preclinical mouse model of hepatic metastasis to instruct effective treatment modalities. Methods in cell biology. 190. 133–150. 1 indexed citations

Nardo, Laura De, S. Santi, Guillermina Ferro‐Flores, et al.. (2024). Comparison of the dosimetry and cell survival effect of 177Lu and 161Tb somatostatin analog radiopharmaceuticals in cancer cell clusters and micrometastases. EJNMMI Physics. 11(1). 94–94.

Frasson, Ilaria, Elena Carbognin, Antonio Rosato, et al.. (2024). Identification of druggable host dependency factors shared by multiple SARS-CoV-2 variants of concern. Journal of Molecular Cell Biology. 16(3). 1 indexed citations

Scaini, Maria Chiara, Jacopo Pigozzo, Luisa Piccin, et al.. (2024). A multiparameter liquid biopsy approach allows to track melanoma dynamics and identify early treatment resistance. npj Precision Oncology. 8(1). 78–78. 8 indexed citations

Moserle, Lidia, Giulia Peserico, Mara Biasin, et al.. (2024). MSI-H Detection by ddPCR in Endoscopic Ultrasound Fine Needle Biopsy (EUS-FNB) from Pancreatic Ductal Adenocarcinoma. International Journal of Molecular Sciences. 25(20). 11090–11090. 1 indexed citations

Castellan, Martina, Guilherme Dias de Melo, Stefania Leopardi, et al.. (2023). Antiviral mechanisms of two broad-spectrum monoclonal antibodies for rabies prophylaxis and therapy. Frontiers in Immunology. 14. 1186063–1186063. 7 indexed citations

Alfieri, Rita, Mara Biasin, Isabella Monia Montagner, et al.. (2023). p53/TP53 Status Assessment in Gastroesophageal Adenocarcinoma. Cancers. 15(10). 2783–2783. 2 indexed citations

10.

Severa, Martina, Fabiana Rizzo, Alessandro Sinigaglia, et al.. (2023). A specific anti‐COVID‐19 BNT162b2 vaccine‐induced early innate immune signature positively correlates with the humoral protective response in healthy and multiple sclerosis vaccine recipients. Clinical & Translational Immunology. 12(3). e1434–e1434. 4 indexed citations

11.

Bolzati, Cristina, Guillermina Ferro‐Flores, Blanca Ocampo‐García, et al.. (2023). Development and Characterization of 99mTc-scFvD2B as a Potential Radiopharmaceutical for SPECT Imaging of Prostate Cancer. International Journal of Molecular Sciences. 25(1). 492–492.

12.

Ferro‐Flores, Guillermina, Enrique Morales-Ávila, Keila Isaac‐Olivé, et al.. (2022). 225Ac-rHDL Nanoparticles: A Potential Agent for Targeted Alpha-Particle Therapy of Tumors Overexpressing SR-BI Proteins. Molecules. 27(7). 2156–2156. 9 indexed citations

13.

Benešová, Iva, Luise Müller, Robert Lischke, et al.. (2022). The Immune Contexture of Liposarcoma and Its Clinical Implications. Cancers. 14(19). 4578–4578. 16 indexed citations

14.

Carpanese, Debora, Laura Meléndez‐Alafort, Laura De Nardo, et al.. (2022). Impact of Different [Tc(N)PNP]-Scaffolds on the Biological Properties of the Small cRGDfK Peptide: Synthesis, In Vitro and In Vivo Evaluations. Molecules. 27(8). 2548–2548. 3 indexed citations

15.

Facchinetti, Antonella, Jacopo Pigozzo, Luisa Piccin, et al.. (2022). Investigating the Retained Inhibitory Effect of Cobimetinib against p.P124L Mutated MEK1: A Combined Liquid Biopsy and in Silico Approach. Cancers. 14(17). 4153–4153. 3 indexed citations

16.

Bolzati, Cristina, Debora Carpanese, Roberta Seraglia, et al.. (2018). [^99mTc][Tc(N)PNP43]-Labeled RGD Peptides As New Probes for a Selective Detection of αvβ₃ Integrin: Synthesis, Structure–Activity and Pharmacokinetic Studies. Journal of Medicinal Chemistry. 61(21). 9596–9610. 18 indexed citations

17.

Cadamuro, Massimiliano, Luisa Sambado, Stefano Indraccolo, et al.. (2016). Low-Dose Paclitaxel Reduces S100A4 Nuclear Import to Inhibit Invasion and Hematogenous Metastasis of Cholangiocarcinoma. Cancer Research. 76(16). 4775–4784. 43 indexed citations

18.

Martorelli, Debora, Elena Muraro, Jessica Dal Col, et al.. (2016). Broadening Specificity and Enhancing Cytotoxicity of Adoptive T Cells for Nasopharyngeal Carcinoma Immunotherapy. Cancer Immunology Research. 4(5). 431–440. 19 indexed citations

19.

Martorelli, Debora, Massimo Guidoboni, Vallì De Re, et al.. (2012). IGKV3 Proteins as Candidate “Off-the-Shelf” Vaccines for Kappa-Light Chain–Restricted B-Cell Non-Hodgkin Lymphomas. Clinical Cancer Research. 18(15). 4080–4091. 11 indexed citations

20.

Bobisse, Sara, Maria Rondina, Anna Merlo, et al.. (2009). Reprogramming T Lymphocytes for Melanoma Adoptive Immunotherapy by T-Cell Receptor Gene Transfer with Lentiviral Vectors. Cancer Research. 69(24). 9385–9394. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact